MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$9,238,000
Net Income
$17,190,000
Net Profit Margin
186.08%
EPS
-$0.08
Unit: Dollar
Revenue Breakdown
PAHResearch And Development Serv...
PAHResearch And Development Serv...
PHILDResearch And Development Se...
Others
Revenue Breakdown
PAHResearch And Development Serv...
PAHResearch And Development Serv...
PHILDResearch And Development Se...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
9,238,000
16,955,000
13,799,000
13,294,000
Research and development
26,412,000
43,075,000
48,935,000
45,542,000
In process research and development
-
-
-1,000
7,476,000
General and administrative
8,900,000
18,746,000
10,904,000
9,390,000
Total operating expenses
35,312,000
61,821,000
59,838,000
62,408,000
Loss from operations
-26,074,000
-44,866,000
-46,039,000
-49,114,000
Interest income
268,000
354,000
447,000
687,000
Interest expense
2,705,000
2,755,000
2,751,000
2,748,000
Remeasurement of warrant liability
-1,602,000
-
-
-
Remeasurement of derivative liability
4,113,000
-
-
-
Gain on debt extinguishment
43,846,000
-
-
-
Other income (loss), net
-4,150,000
603,000
1,017,000
2,954,000
Total other income, net
42,974,000
-1,798,000
-1,287,000
893,000
Loss before provision (benefit) for income taxes
-
-
-47,326,000*
-48,221,000
Provision (benefit) for income taxes
-
-
-88,000*
0
Net income (loss)
16,900,000
-46,664,000
-47,238,000
-48,221,000
Foreign currency translation
291,000
1,192,000
-20,000
-130,000
Unrealized loss on marketable securities
-1,000
-67,000
-22,000
111,000
Other comprehensive income (loss)
290,000
1,125,000
-42,000
-19,000
Comprehensive income (loss)
17,190,000
-45,539,000
-47,280,000
-48,240,000
Basic EPS
0.05
-0.2
-0.204
-0.21
Diluted EPS
-0.08
-0.2
-0.204
-0.21
Basic Average Shares
320,014,255
234,137,364
232,001,528
227,981,475
Diluted Average Shares
328,776,495
234,137,364
232,001,528
227,981,475
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Gain on debt
extinguishment
$43,846,000
Remeasurement of derivative
liability
$4,113,000
PAHResearch And Development
Services Expenses...
$3,595,000
(12.84%↑ Y/Y)
PAHResearch And Development
Services Performance...
$2,623,000
(-21.84%↓ Y/Y)
PHILDResearch And Development
Services Expenses...
$1,763,000
(-36.83%↓ Y/Y)
PAHCommercial Expenses
Subject To...
$747,000
(-45.51%↓ Y/Y)
PHILDResearch And Development
Services Performance...
$486,000
(-17.06%↓ Y/Y)
Effects Of Exchange Rate
$24,000
(175.00%↑ Y/Y)
Remeasurement of warrant
liability
-$1,602,000
Interest income
$268,000
(-50.55%↓ Y/Y)
Total other income,
net
$42,974,000
(8634.55%↑ Y/Y)
Foreign currency
translation
$291,000
(106.94%↑ Y/Y)
Other income (loss),
net
-$4,150,000
(-254.05%↓ Y/Y)
Revenue From Contract
With Customer...
$9,238,000
Interest expense
$2,705,000
(-1.42%↓ Y/Y)
Net income (loss)
$16,900,000
(144.16%↑ Y/Y)
Other comprehensive
income (loss)
$290,000
(106.80%↑ Y/Y)
Loss from operations
-$26,074,000
(32.74%↑ Y/Y)
Unrealized loss on
marketable securities
-$1,000
(98.55%↑ Y/Y)
Total revenue
$9,238,000
(-19.59%↓ Y/Y)
Comprehensive income (loss)
$17,190,000
(140.41%↑ Y/Y)
Total operating
expenses
$35,312,000
(-29.73%↓ Y/Y)
Research and development
$26,412,000
(-36.47%↓ Y/Y)
General and
administrative
$8,900,000
(2.55%↑ Y/Y)
Buy us a coffee
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)